Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Fractyl Health, Inc. and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Radiopharm Theranostics Limited - Sponsored ADR is the larger, with a market value of $14.0M against $11.9M — 1.2× the size. Across the 7 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 4 and Fractyl Health, Inc. on 3.

Valuation

Metric GUTS RADX Biotechnology median
P/E n/m — 10.26
P/S 127.89 — 9.18
P/B n/m n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.06 n/m 0.65
EV/Sales (51.61) n/m 8.98
Earnings yield (1,173.80%) — (34.89%)
Free cash flow yield (697.71%) 0.00% (24.52%)

Profitability

Metric GUTS RADX Biotechnology median
Gross margin 46.24% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% 0.00% (50.12%)
Return on assets (146.75%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS RADX Biotechnology median
Revenue growth (TTM) (22.50%) — 6.26%
EPS growth (last fiscal year) (14.81%) (1.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric GUTS RADX Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 1.16 4.89
Net debt to EBITDA 0.53 0.08 1.01

Dividend

Metric GUTS RADX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS RADX Biotechnology median
Market cap 11.88m 13.96m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack